LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2‐macrophage infiltration through activating AKT‐IKKβ‐p65 axis

Author:

Pan Banglun1,Shen Shuling1,Zhao Jun2,Zhang Zhu1,Ye Dongjie1,Zhang Xiaoxia1,Yao Yuxin1,Luo Yue1,Wang Xiaoqian13,Tang Nanhong134ORCID

Affiliation:

1. Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery Fujian Medical University Union Hospital Fuzhou China

2. Department of Laboratory Medicine Fujian Medical University Union Hospital Fuzhou China

3. Cancer Center of Fujian Medical University, Fujian Medical University Union Hospital Fuzhou China

4. Key Laboratory of Clinical Laboratory Technology for Precision Medicine (Fujian Medical University) Fujian Province University Fuzhou China

Abstract

AbstractLAIR1, a receptor found on immune cells, is capable of binding to collagen and is involved in immune‐related diseases. However, the precise contribution of LAIR1 expressed on hepatocellular carcinoma (HCC) cells to tumor microenvironment is still unclear. In our study, bioinformatics analysis and immunofluorescence were employed to study the correlation between LAIR1 levels and clinical indicators. Transwell and scratch tests were used to evaluate how LAIR1 affected the migration and invasion of HCC cells. The chemotactic capacity and alternative activation of macrophages were investigated using RT‐qPCR, transwell, and immunofluorescence. To investigate the molecular mechanisms, transcriptome sequencing analysis, Western blot, nucleus/cytoplasm fractionation, ELISA, and cytokine microarray were employed. We revealed a significant correlation between the presence of LAIR1 and an unfavorable outcome in HCC. We indicated that LAIR1 promoted migration and invasion of HCC cells through the AKT‐IKKβ‐p65 axis. Additionally, the alternative activation and infiltration of tumor‐associated macrophages induced by LAIR1 were reliant on the upregulation of IL6 and CCL5 within this axis, respectively. In conclusion, blocking LAIR1 was found to be an effective approach in combating the cancerous advancement of HCC.

Funder

Natural Science Foundation of Fujian Province

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3